CUSIP 221015100COMCRVSQ4 2025
44 filings · latest Feb 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Orbimed Advisors LLC | 7.17M | $55.17M |
| 2 | Blackrock, Inc. | 5.06M | $38.93M |
| 3 | Vanguard Group Inc | 3.87M | $29.83M |
| 4 | Morgan Stanley | 3.57M | $27.47M |
| 5 | Adams Street Partners LLC | 3.28M | $25.22M |
| 6 | Point72 Asset Management, L.P. | 2.88M | $22.14M |
| 7 | State Street Corp | 2.79M | $21.47M |
| 8 | Mpm Bioimpact LLC | 2.74M | $21.13M |
| 9 | Vivo Capital, LLC |
| 4 | Jan 27, 2026 | Orbimed Advisors LLC | 13D/A | 10.3% | — | SEC |
| 5 | Oct 17, 2025 | Blackrock, Inc. | 13G | 5.4% | 4.02M | SEC |
| 6 | Aug 14, 2025 | Samlyn Capital, LLC | 13G/A | — | — | SEC |
| 7 | May 15, 2025 | Samlyn Capital, LLC | 13G/A | 6.0% | — | SEC |
| 8 | May 14, 2025 | Orbimed Advisors LLC | 13D/A | 12.2% | — | SEC |
| 9 | May 1, 2025 | Orbimed Advisors LLC | 13D/A | 13.8% | — | SEC |
| 10 | Feb 14, 2025 | Samlyn Capital, LLC | 13G/A | 9.8% | — | SEC |
See the full Schedule 13D/13G history for Corvus Pharmaceuticals Inc.
Unlock full history| 2.23M |
| $17.21M |
| 10 | Geode Capital Management, LLC | 1.47M | $11.35M |